How to protect your digital and mobile health innovations

Patent protection is becoming increasingly important for mobile health developers as more devices and applications join the connected world.  David Dykeman, Greenberg Traurig The emergence of medical mobile device apps and wearables is revolutionizing healthcare. Home monitoring, big data, the Internet of things (IoT) and personalized medicine are putting mobile health (“mHealth”) apps at users’

Intellectual property: How medtech startups can protect it

All companies begin with an idea. The details of protecting intellectual property, however, can be daunting, especially if your idea is in the field of medical technology. N. Scott Pierce and Alexander Adam,  Hamilton, Brook, Smith & Reynolds PC Starting a medical device company requires a vast array of knowledge, including knowledge about almost every

Why you should care about intellectual property

What do early-stage companies really need to focus on? Patent attorney David Dykeman says, first and foremost, that its intellectual property protection. Dykeman –who co-chairs Greenberg Traurig’s global Life Sciences & Medical Technology Group – will speak at DeviceTalks Boston on October 2. We asked him to give us some ideas on the important issues surrounding medtech

Scapa Healthcare receives patent for wound dressings

Scapa Healthcare was recently granted a patent for its hydrogel wound dressings for chest cavities. The patent offers protection in Germany, France and the U.K. Partnered with Prometheus Medical, the patented design was created to help with potentially fatal chest wounds in combat that could have been caused by a bullet, shrapnel or stabbing. It

Two Supreme Court decisions take a whack at patent holders

Landmark U.S. Supreme Court decisions signal an effort to shoot down patent trolls, but one expert says small business could get caught in the crosshairs. Recent Supreme Court decisions dealing with patents have some experts concerned that, rather than clarifying the rules and combating patent trolls, the rulings will instead weaken the rights of patent

Patenting strategies for medtech startups

Patenting may be a daunting task, but it is critical to facilitating a company’s success. Here are some tips on how and when to think about patents. David Dykeman has advised numerous startup companies during his more than 20 years practicing patent law. The intellectual property attorney serves as co-chair of the global life sciences

Three IP issues in outsourcing medical devices

Andrea D. Merin/Associate/Wolf Greenfield Neil P. Ferraro/Shareholder/Wolf Greenfield You’ve developed an idea for a new medical device, and you’ve even found a manufacturer to actually create it. Don’t forget to protect your product from those who might take credit for it or create a competing product. In order to do so, keep the following three issues

Medtech patenting: How you might be leaving money on the table

Jackie Hutter, The Hutter Group Entrepreneurs bringing innovative new medical devices to market often make a significant mistake when they go to patent their work. I frequently find that these entrepreneurs focus their patenting efforts on the particular medical device product without also recognizing that a wider scope of coverage for their innovations may be

ZDi Solutions receives FDA approval for patented proton therapy and conventional radiation therapy positioning devices

ZDi Solutions announced that it has received approval from the U.S. Food and Drug Administration for its Z-System patient positioning devices for proton therapy and conventional radiation therapy. The company announced in late September that it has begun marketing both in the U.S. and internationally. The system is comprised of the Z-Box, Z-Square and Z-Tilt.

Three IP issues in outsourcing medical devices

By Andrea D. Merin and Neil P. Ferraro You’ve developed an idea for a new medical device and you’ve even found a manufacturer to actually create it. Don’t forget to protect your product from those who might take credit for it or create a competing product. In order to do so, keep the following three

Investors, insiders show optimism in Retractable Technologies

Investors in Retractable Technologies Inc. (NYSE:RVP) tell Medical Design & Outsourcing that they are quietly upping their stakes in the syringe maker, believing the company could be poised for a breakthrough with the latest iteration of its retracting needle technology. Although Retractable Technologies swung to second-quarter red ink, posting losses of -$833,000, or -3¢ per share, sales grew 12.8%

Fisher & Paykel Healthcare file patent infringement proceedings against ResMed

Fisher & Paykel Healthcare announced that it has filed patent infringement proceedings in the U.S. District Court for the Central District of California seeking judgment that ResMed’s AirSense 10 and AirCurve 10 range of flow generator products, ClimateLineAir heated air tubing for use with such flow generator products and Swift LT and Swift FX masks,

New Obi robotic dining device a breakthrough
for people living with physical challenges

The simple act of eating a meal will become more dignified and enjoyable for many people with physical challenges with the launch of Obi, a revolutionary robotic dining device. Obi blends cutting-edge robotics, elegant design, intuitive controls and a friendly personality to give individuals who are fed by others the ability to take control of

The problem with medical device patent strategies

By Jackie Hutter, founder, The Hutter Group IP strategists spend considerable time “Monday Morning Quarterbacking” patent strategy for medical device inventions for the purposes of valuation and commercialization. We are often asked to review medical device patents to provide opinions on commercial potential. For some of these reviews, we are forced to conclude that the medical

PathMaker Neurosystems announces key patent issuance by U.S. Patent and Trademark Office for fundamental technology covering MyoRegulator

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems for the treatment of patients with neuromotor disorders, announced that the U.S. Patent and Trademark Office has granted a fundamental patent (U.S. Patent 9,283,391) covering its proprietary DoubleStim technology that forms the basis of our MyoRegulator system, a first-in-class non-invasive device now in human clinical trials